Baş ve Boyun Vasküler Anomalileri

Graham ME, Perkins JA, Grimmer JF. Vascular Anomalies of the Head and Neck [Internet]. Second Edi. Cummings Pediatric Otolaryngology. Elsevier Inc.; 2021. 344–363 p. Available from: https://doi.org/10.1016/B978-0-323-69618-0.00025-1
Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin. 1998;16(3):455–88.
Perkins JA, Sidhu M, Manning SC, Ghioni V, Sze R. Three-dimensional CT angiography imaging of vascular tumors of the head and neck. Int J Pediatr Otorhinolaryngol. 2005;69(3):319–25.
Mukerji SS, Osborn AJ, Roberts J, Valdez TA. Kaposiform hemangioendothelioma (with Kasabach Merritt syndrome) of the head and neck: Case report and review of the literature. Int J Pediatr Otorhinolaryngol. 2009;73(10):1474–6.
Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: A systematic review of the literature. Stroke. 2012;43(6):1672–4.
Rivière J, Mirzaa GM, Roak BJO, Beddaoui M, Conway RL, St-onge J, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012;44(8):934–40.
Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M. Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol. 2013;4(4):179–83.
Uebelhoer M, Nätynki M, Kangas J, Mendola A, Nguyen HL, Soblet J, et al. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet. 2013;22(17):3438–48.
Bittles MA, Sidhu MK, Sze RW, Finn LS, Ghioni V, Perkins JA. Multidetector CT angiography of pediatric vascular malformations and hemangiomas: Utility of 3-D reformatting in differential diagnosis. Pediatr Radiol. 2005;35(11):1100–6.
Balakrishnan K, Majesky M, Perkins JA. Head and neck lymphatic tumors and bony abnormalities: A clinical and molecular review. Lymphat Res Biol. 2011;9(4):205–12.
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Vol. 69, Plastic and Reconstructive Surgery. 1982. p. 412–20.
Vikkula M. Vascular pathologies: Angiogenomics: Towards a genetic nosology and understanding of vascular anomalies. Eur J Hum Genet. 2007;15(8):821–2.
Tille JC, Pepper MS. Hereditary vascular anomalies: New insights into their pathogenesis. Arterioscler Thromb Vasc Biol. 2004;24(9):1578–90.
Wallace GMF, Shovlin CL. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax. 2000;55(8):685–90.
Revencu N, Boon LM, Mendola A, Cordisco MR, Dubois J, Clapuyt P, et al. RASA1 Mutations and Associated Phenotypes in 68 Families with Capillary Malformation-Arteriovenous Malformation. Hum Mutat. 2013;34(12):1632–41.
Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: Update 2012. Brain. 2012;135(5):1348–69.
Zhou XP, Hampel H, Thiele H, Gorlin RJ, Hennekam RCM, Parisi M, et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet. 2001;358(9277):210–1.
Hendriks YMC, Verhallen JTCM, Van der Smagt JJ, Kant SG, Hilhorst Y, Hoefsloot L, et al. Bannayan-Riley-Ruvalcaba syndrome: Further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer. 2003;2(2):79–85.
Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics. 2006;118(3):882–7.
Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective Study of Infantile Hemangiomas: Demographic, Prenatal, and Perinatal Characteristics. J Pediatr. 2007;150(3):291–4.
North PE, Waner M, Buckmiller L, James CA, Mihm MC. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol. 2006;15(6):303–17.
North PE, Waner M, Mizeracki A, Mihm MC. GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31(1):11–22.
Gold L, Nazarian LN, Johar AS, Rao VM. Characterization of maxillofacial soft tissue vascular anomalies by ultrasound and color doppler imaging: An adjuvant to computed tomography and magnetic resonance imaging. J Oral Maxillofac Surg. 2003;61(1):19–31.
Bauland CG, Smit JM, Bartelink LR, Zondervan HA, Spauwen PHM. Hemangioma in the newborn: increased incidence after chorionic villus sampling. Prenat Diagn. 2010;30(10):913–7.
Bauland CG, Smit JM, Scheffers SM, Bartels RH, Van Den Berg P, Zeebregts CJ, et al. Similar risk for hemangiomas after amniocentesis and transabdominal chorionic villus sampling. J Obstet Gynaecol Res. 2012;38(2):371–5.
Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment. Birth Defects Res. 2017;109(11):809–15.
Poetke M, Frommeld T, Berlien HP. PHACE syndrome: New views on diagnostic criteria. Eur J Pediatr Surg. 2002;12(6):366–74.
Garzon MC, Epstein LG, Heyer GL, Frommelt PC, Orbach DB, Baylis AL, et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr. 2016;178:24-33.e2.
Drolet BA, Dohil M, Golomb MR, Wells R, Murowski L, Tamburro J, et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics. 2006;117(3):959–64.
Doco-fenzy M, Mauran P, Lebrun JM, Bock S, Bednarek N, Albuisson J, et al. A Prospective Study of PHACE Syndrome in Infantile Hemangiomas: Demographic Features, Clinical Findings, and Complications. Am J Hum Genet. 2006;140(9):975–86.
Haggstrom AN, Skillman S, Garzon MC, Drolet BA, Holland K, Matt B, et al. Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol - Head Neck Surg. 2011;137(7):680–7.
Alfons Krol, Carol MacArthur. Congenital Hemangiomas Rapidly Involuting and Noninvoluting Congenital Hemangiomas. Arch Facial Plast Surg [Internet]. 2005;7:307–11. Available from: https://www.liebertpub.com/doi/pdf/10.1001/archfaci.7.5.307
Feito-Rodríguez M, Sánchez-Orta A, De Lucas R, López-Gutiérrez JC, Ruiz-Bravo E, Baselga E, et al. Congenital tufted angioma: A multicenter retrospective study of 30 cases. Pediatr Dermatol. 2018;35(6):808–16.
Lyons LL, North PE, Mac-Moune Lai F, Stoler MH, Folpe AL, Weiss SW. Kaposiform hemangioendothelioma a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol. 2004;28(5):559–68.
Liu XH, Li JY, Qu XH, Yan WL, Zhang L, Yang C, et al. Treatment of kaposiform hemangioendothelioma and tufted angioma. Int J Cancer. 2016;139(7):1658–66.
Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, et al. Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr. 1997;130(4):631–40.
Rodriguez V, Lee A, Witman PM, Anderson PA. Kasabach-Merritt phenomenon: Case series and retrospective review of the mayo clinic experience. J Pediatr Hematol Oncol. 2009;31(7):522–6.
Mahajan P, Margolin J, Iacobas I. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options. Clin Med Insights Blood Disord. 2017;10:0–4.
Williams EF, Stanislaw P, Dupree M, Mourtzikos K, Mihm M, Shannon L. Hemangiomas in infants and children. An algorithm for intervention. Arch Facial Plast Surg. 2000;2(2):103–11.
Drolet B. Initiation and Use of Propranolol for Infantile Hemangioma : Report of a Consensus Conference abstract. Pediatrics. 2013;131(1):128–40.
Ryan J. Propranolol Use for Infantile Hemangiomas. JAMA Otolaryngol - Head Neck Surg. 2013;139(2):153–6.
Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol - Head Neck Surg. 2011;144(1):78–84.
Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, et al. Safety of oral propranolol for the treatment of infantile hemangioma: A systematic review. Pediatrics. 2016;138(4):e20160353.
Moyakine AV, Kerstjens JM, Spillekom-Van Koulil S, Van Der Vleuten CJM. Propranolol treatment of infantile hemangioma (IH) is not associated with developmental risk or growth impairment at age 4 years. J Am Acad Dermatol [Internet]. 2016;75(1):59-63.e1. Available from: http://dx.doi.org/10.1016/j.jaad.2016.02.1218
Moyakine AV, Spillekom-van Koulil S, van der Vleuten CJM. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age. J Am Acad Dermatol [Internet]. 2017;77(1):105–8. Available from: http://dx.doi.org/10.1016/j.jaad.2017.01.025
González-Llorente N, del Olmo-Benito I, Muñoz-Ollero N, Descalzo MA, García-Doval I, Torrelo A. Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma. Pediatr Dermatol. 2017;34(5):554–8.
Bingham MM, Saltzman B, Vo NJ, Perkins JA. Propranolol reduces infantile hemangioma volume and vessel density. Otolaryngol - Head Neck Surg (United States). 2012;147(2):338–44.
Poetke M, Philipp C, Berlien HP. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: Treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000;136(5):628–32.
Waner M. Recent developments in lasers and the treatment of birthmarks. Arch Dis Child. 2003;88(5):372–4.
Witman PM, Wagner AM, Scherer K, Waner M, Frieden IJ. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med. 2006;38(2):116–23.
Vijayasekaran S, White DR, Hartley BEJ, Rutter MJ, Elluru RG, Cotton RT. Open excision of subglottic hemangiomas to avoid tracheostomy. Arch Otolaryngol - Head Neck Surg. 2006;132(2):159–63.
Van Den Abbeele T, Triglia JM, Lescanne E, Roger G, Nicollas R, Ployet MJ, et al. Surgical removal of subglottic hemangiomas in children. Laryngoscope. 1999;109(8):1281–6.
Michelle Levi, Kodsi SR, Schwartz SR, Blei F, Millman A, Steele M. Surgical Treatment of Capillary Hemangiomas Causing Ambly- opia. J Am Assoc Pediatr Ophthalmol Strabismus. 2007;11(3):230–4.
Waner M, Buckmiller L, Suen JY. Surgical management of hemangiomas of the head and neck. Oper Tech Otolaryngol - Head Neck Surg. 2002;13(1):77–84.
Keller RG, Stevens S, Hochman M. Modern management of nasal hemangiomas. JAMA Facial Plast Surg. 2017;19(4):327–32.
Rahbar R, Nicollas R, Roger G, Kim H, Garabedian EN, McGill TJ. The biology and management of subglottic hemangioma; past, present, future. Laryngoscope. 2004;114(11):1880–91.
Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: Multicenter study. Int J Pediatr Otorhinolaryngol. 2009;73(9):1187–91.
Perkins JA, Duke W, Chen E, Manning S. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol - Head Neck Surg [Internet]. 2009;141(2):207–12. Available from: http://dx.doi.org/10.1016/j.otohns.2009.04.013
Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131(4):643–6.
Darrow DH. Management of Infantile Hemangiomas of the Airway. Otolaryngol Clin North Am [Internet]. 2018;51(1):133–46. Available from: https://doi.org/10.1016/j.otc.2017.09.001
Parhizkar N, Manning SC, Jr AFI, Finn LS, Chen EY, Perkins JA. How Airway Venous Malformations Differ From Airway Infantile Hemangiomas. Arch Otolaryngol - Head Neck Surg. 2011;137(4):352–7.
Teresa MO, Alexander RE, Lando T, Grant NN, Perkins JA, Blitzer A, et al. Segmental hemangiomas of the upper airway. Laryngoscope. 2009;119(11):2242–7.
Perkins JA, Chen EY, Hoffer FA, Manning SC. Proposal for staging airway hemangiomas. Otolaryngol - Head Neck Surg [Internet]. 2009;141(4):516–21. Available from: http://dx.doi.org/10.1016/j.otohns.2009.06.751
Naiman AN, Ayari S, Froehlich P. Controlled Risk of Stenosis after Surgical Excision of Laryngeal Hemangioma. Arch Otolaryngol - Head Neck Surg. 2003;129(12):1291–5.
Truong MT, Perkins JA, Messner AH, Chang KW. Propranolol for the treatment of airway hemangiomas: A case series and treatment algorithm. Int J Pediatr Otorhinolaryngol [Internet]. 2010;74(9):1043–8. Available from: http://dx.doi.org/10.1016/j.ijporl.2010.06.001
Perkins JA, Oliaei S, Garrison MM, Manning SC, Christakis DA. Airway procedures and hemangiomas: Treatment patterns and outcome in U.S. pediatric hospitals. Int J Pediatr Otorhinolaryngol. 2009;73(9):1302–7.
Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma; A rational approach to management. Laryngoscope. 2001;111(11):1929–37.
Luks VL, Kamitaki N, Vivero MP, Uller W, Bovée JVMG, Rialon KL, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015;166(4):1048–54.
Chen EY, Hostikka SL, Oliaei S, Duke W, Schwartz SM, Perkins JA. Similar histologic features and immunohistochemical staining in microcystic and macrocystic lymphatic malformations. Lymphat Res Biol. 2009;7(2):75–80.
Ganapathy R, Guven M, Sethna F, Vivekananda U, Thilaganathan B. Natural history and outcome of prenatally diagnosed cystic hygroma. Prenat Diagn. 2004;24(12):965–8.
Shulman LP, Emerson DS, Grevengood C, Felker RE, Gross SJ, Phillips OP, et al. Clinical course and outcome of fetuses with isolated cystic nuchal lesions and normal karyotypes detected in the first trimester. Am J Obstet Gynecol [Internet]. 1994;171(5):1278–81. Available from: http://dx.doi.org/10.1016/0002-9378(94)90147-3
Burrows PE, Mason KP. Percutaneous Treatment of Low Flow Vascular Malformations. J Vasc Interv Radiol. 2004;15(5):431–45.
Farrell PT. Prenatal diagnosis and intrapartum management of neck masses causing airway obstruction. Paediatr Anaesth. 2004;14(1):48–52.
Dighe MK, Peterson SE, Dubinsky TJ, Perkins J, Cheng E. EXIT procedure: Technique and indications with prenatal imaging parameters for assessment of airway patency. Radiographics. 2011;31(2):511–26.
Bence CM, Wagner AJ. Ex utero intrapartum treatment (EXIT) procedures. Semin Pediatr Surg [Internet]. 2019;28(4). Available from: https://doi.org/10.1053/j.sempedsurg.2019.07.003
Kirsh AL, Cushing SL, Chen EY, Schwartz SM, Perkins JA. Tertiary lymphoid organs in lymphatic malformations. Lymphat Res Biol. 2011;9(2):85–92.
Tempero RM, Hannibal M, Finn LS, Manning SC, Cunningham ML, Perkins JA. Lymphocytopenia in children with lymphatic malformation. Arch Otolaryngol - Head Neck Surg. 2006;132(1):93–7.
Perkins JA, Tempero RM, Hannibal MC, Manning SC. Clinical outcomes in lymphocytopenic lymphatic malformation patients. Lymphat Res Biol. 2007;5(3):169–73.
Lee S, Finn L, Sze RW, Perkins JA, Sie KC. Gorham Stout Syndrome (Disappearing Bone Disease): Two Additional Case Reports and a Review of the Literature. Arch Otolaryngol - Head Neck Surg. 2003;129(12):1340–3.
Perkins JA, Maniglia C, Magit A, Sidhu M, Manning SC, Chen EY. Clinical and radiographic findings in children with spontaneous lymphatic malformation regression. Otolaryngol - Head Neck Surg [Internet]. 2008;138(6):772–7. Available from: http://dx.doi.org/10.1016/j.otohns.2008.02.016
Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds JL, Hoffer FA, et al. Lymphatic malformations: Review of current treatment. Otolaryngol - Head Neck Surg [Internet]. 2010;142(6):795-803.e1. Available from: http://dx.doi.org/10.1016/j.otohns.2010.02.026
Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: A systematic review. Otolaryngol - Head Neck Surg. 2008;138(4):418–24.
Harsha WJ, Perkins JA, Lewis CW, Manning SC. Pediatric admissions and procedures for lymphatic malformations in the United States: 1997 and 2000. Lymphat Res Biol. 2005;3(2):58–65.
Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006;17(10):1639–48.
Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg. 2008;43(3):451–60.
Riechelmann H, Muehlfay G, Keck T, Maufeldt T, Rettinger G. Total, subtotal, and partial surgical removal of cervicofacial lymphangiomas. Arch Otolaryngol - Head Neck Surg. 1999;125(6):643–8.
Lee GS, Perkins JA, Oliaei S, Manning SC. Facial nerve anatomy, dissection and preservation in lymphatic malformation management. Int J Pediatr Otorhinolaryngol. 2008;72(6):759–66.
Chiara J, Kinney G, Slimp J, Lee GS, Oliaei S, Perkins JA. Facial nerve mapping and monitoring in lymphatic malformation surgery. Int J Pediatr Otorhinolaryngol. 2009;73(10):1348–52.
Suver DW, Perkins JA, Manning SC. Somatostatin treatment of massive lymphorrhea following excision of a lymphatic malformation. Int J Pediatr Otorhinolaryngol. 2004;68(6):845–50.
Adams DM, III CCT, Hammill AM, Vinks AA, Patel MN, Chaudry G. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. Pediatrics. 2016;137(2):e20153257.
Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: A systematic review. Otolaryngol - Head Neck Surg (United States). 2012;147(4):627–39.
Balakrishnan K, Edwards TC, Perkins JA. Functional and symptom impacts of pediatric head and neck lymphatic malformations: Developing a patient-derived instrument. Otolaryngol - Head Neck Surg (United States). 2012;147(5):925–31.
Mellor RH, Brice G, Stanton AWB, French J, Smith A, Jeffery S, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007;115(14):1912–20.
KD H, JB M, HP K. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110(7):1625–35.
Bisdorff A, Mulliken JB, Carrico J, Robertson RL, Burrows PE. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. Am J Neuroradiol. 2007;28(2):335–41.
Mazereeuw-Hautier J, Syed S, Leisner RI, Harper JI. Extensive venous/lymphatic malformations causing life-threatening haematological complications. Br J Dermatol. 2007;157(3):558–63.
Lee A, Driscoll D, Gloviczki P, Clay R, Shaughnessy W, Stans A. Evaluation and management of pain in patients with Klippel-Trenaunay syndrome: A review. Pediatrics. 2005;115(3):744–9.
Tieu DD, Ghodke B V., Vo NJ, Perkins JA. Single-stage excision of localized head and neck venous malformations using preoperative glue embolization. Otolaryngol - Head Neck Surg (United States). 2013;148(4):678–84.
Buckmiller LM, Richter GT, Waner M, Suen JY. Use of recombinant factor VIIa during excision of vascular anomalies. Laryngoscope. 2007;117(4):604–9.
Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: Complications and results. Plast Reconstr Surg. 1999;104(1):1–15.
Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous Malformations of the Head and Neck: Natural History and Management. Vol. 102, Plastic & Reconstructive Surgery. 1998. p. 643–54.
Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, et al. Capillary Malformation-Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations. Am J Hum Genet. 2003;73(6):1240–9.
Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am. 2002;10(2):363–88.
Bradley JP, Zide BM, Berenstein A, Longaker MT. Large arteriovenous malformations of the face: Aesthetic results with recurrence control. Plast Reconstr Surg. 1999;103(2):351–61.
Persky MS, Yoo HJ, Berenstein A. Management of Vascular Malformations of the Mandible and Maxilla. Laryngoscope. 2003;113(11):1885–92.
Ch’ng S, Tan ST. Facial port-wine stains - clinical stratification and risks of neuro-ocular involvement. J Plast Reconstr Aesthetic Surg. 2008;61(8):889–93.
Comi AM. Sturge-Weber syndrome [Internet]. 1st ed. Vol. 132, Handbook of Clinical Neurology. Elsevier B.V.; 2015. 157–168 p. Available from: http://dx.doi.org/10.1016/B978-0-444-62702-5.00011-1
Sanchez-Carpintero I, Mihm MC, Mizeracki A, Waner M, North PE. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol. 2004;50(4):608–12.
Jasim ZF, Handley JM. Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol. 2007;57(4):677–82.